On May 14, the British Medical Journal published an article presenting the results of a multi-center trial of hydroxychloroquine (HCQ) in Chinese patients with COVID-19 in February. It concluded: “Administration of hydroxychloroquine did not result in a significantly higher probability of negative conversion than standard of care alone in patients admitted to hospital […]